Literature DB >> 14573383

Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro.

Mark O Cunningham1, Gavin L Woodhall, Roland S G Jones.   

Abstract

The anticonvulsant, valproic acid (VPA), has a very wide spectrum of clinical activity and has conventionally been considered to act by enhancing inhibitory GABAergic activity, either by increasing GABA levels and its subsequent release or by enhancing postsynaptic GABA responses. However, the pharmacology of VPA is complex and other mechanisms may well contribute. In the present study, we examined the effect of the drug on the release of GABA and glutamate at synapses in the rat entorhinal cortex, using the whole-cell patch clamp technique to record spontaneous excitatory (sEPSCs) and inhibitory postsynaptic currents (sIPSCs). VPA reduced the frequency but not the amplitude of both spontaneous sEPSCs and sIPSCs, with a more pronounced effect on the former. However, VPA had no effect on miniature, monoquantal events recorded in the presence of TTX, suggesting that the reduction in release occurred via blockade of Na(+)-channels in the presynaptic neurones. In addition, VPA also prolonged the decay time of sIPSCs, and this effect was occluded by a benzodiazepine agonist, zolpidem. These data suggest that in addition to presynaptic effects on release, VPA can potentiate postsynaptic responses, possibly by interaction with the benzodiazepine regulatory site of the GABA(A) receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573383     DOI: 10.1016/s0028-3908(03)00270-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  17 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Modulation of synaptic transmission and analysis of neuroprotective effects of valproic Acid and derivates in rat embryonic motoneurons.

Authors:  D Ragancokova; Y Song; H Nau; R Dengler; K Krampfl; S Petri
Journal:  Cell Mol Neurobiol       Date:  2010-04-27       Impact factor: 5.046

3.  Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.

Authors:  Derek Daigle; Lyn Gradoville; David Tuck; Vince Schulz; Ruth Wang'ondu; Jianjiang Ye; Kelly Gorres; George Miller
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

4.  Effect of HDAC inhibitors on neuroprotection and neurite outgrowth in primary rat cortical neurons following ischemic insult.

Authors:  Mohammad Rakibul Hasan; Ji-Hye Kim; Youn Jung Kim; Kyoung Ja Kwon; Chan Young Shin; Hahn Young Kim; Seol-Heui Han; Dong-Hee Choi; Jongmin Lee
Journal:  Neurochem Res       Date:  2013-06-22       Impact factor: 3.996

5.  Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro.

Authors:  S D Greenhill; R S G Jones
Journal:  Neuroscience       Date:  2010-02-16       Impact factor: 3.590

6.  Perturbation of the Vacuolar ATPase: A NOVEL CONSEQUENCE OF INOSITOL DEPLETION.

Authors:  Rania M Deranieh; Yihui Shi; Maureen Tarsio; Yan Chen; J Michael McCaffery; Patricia M Kane; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

7.  Effects of flunarizine on spontaneous synaptic currents in rat neocortex.

Authors:  P T Golumbek; J M Rho; W J Spain; J F M van Brederode
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-01       Impact factor: 3.000

8.  Exposure to histone deacetylase inhibitors during Pavlovian conditioning enhances subsequent cue-induced reinstatement of operant behavior.

Authors:  Kyle L Ploense; Kerry A Kerstetter; Matthew A Wade; Nicholas C Woodward; Dan Maliniak; Michael Reyes; Russell S Uchizono; Timothy W Bredy; Tod E Kippin
Journal:  Behav Pharmacol       Date:  2013-06       Impact factor: 2.293

Review 9.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

10.  Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex.

Authors:  Gabriella Gobbi; Luigi Janiri
Journal:  Psychopharmacology (Berl)       Date:  2006-02-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.